Scientists explore deficits in processing speed in individuals with spinal cord injury A team of rehabilitation researchers has studied processing speed deficits in individuals with spinal cord injury (SCI), comparing their brain activation patterns with those of healthy age-matched controls, and older healthy individuals. They found that the SCI group and older controls had similar […]
Get Care Now 703.876.9300
December 2020
Medical Articles & News
Unique susceptibility to unique Sars-CoV-2 variants and vaccines Individuals with different genetic variants in their immune system components often have very different immune responses to Sars-CoV-2. They also will have different responses to vaccines. By the same token, newly emerged variants in Sars-Cov-2 can elicit different immune responses in identical immune systems. In the larger […]
Researcher urges caution using remdesivir to treat COVID-19 While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its kind that the U.S. Food and Drug Administration (FDA) has approved […]
A pursuit of better testing to sort out the complexities of ADHD The introduction of computer simulation to the identification of symptoms in children with attention deficit/hyperactivity disorder (ADHD) has potential to provide an additional objective tool to gauge the presence and severity of behavioral problems, Ohio State University researchers suggest in a new publication. […]
Large transporter protein linked to schizophrenia Scientists have suspected mutations in a cellular cholesterol transport protein are associated with psychiatric disorders, but have found it difficult to prove this and to pinpoint how it happens. Now, Kazumitsu Ueda of Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) and colleagues in Japan have provided evidence that […]
Protein twist and squeeze confers cancer drug resistance In 1986, cellular biochemist Kazumitsu Ueda, currently at Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS), discovered that a protein called ABCB1 could transport multiple chemotherapeutics out of some cancer cells, making them resistant to treatment. How it did this has remained a mystery for the past […]
Study examines the most effective COVID-19 control policies With the arrival of effective vaccines for the COVID-19 virus, the end of the pandemic is on the horizon but in the short term the virus continues to spread. Go to Source
Sustained cellular immune dysregulation in individuals recovering from COVID-19 COVID-19, which has killed 1.7 million people worldwide, does not follow a uniform path. Go to Source
Anticoagulants not tied to higher risk for GI bleed in COVID-19 (HealthDay)—Use of anticoagulation or antiplatelet agents is not a risk factor for gastrointestinal (GI) bleeding among hospitalized COVID-19 patients, according to a study published online Dec. 20 in the Journal of Internal Medicine. Go to Source
SARS-CoV-2 reinfection risk drops with presence of antibodies (HealthDay)—Health care workers with anti-spike or anti-nucleocapsid immunoglobulin G (IgG) antibodies have a reduced risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in the following six months, according to a study published online Dec. 23 in the New England Journal of Medicine. Go to Source